scholarly journals Influence of pre-treatment structural brain measures on effects of action-based cognitive remediation on executive function in partially or fully remitted patients with bipolar disorder

2022 ◽  
Vol 56 ◽  
pp. 50-59
Author(s):  
Mogensen MB ◽  
J Macoveanu ◽  
Knudsen GM ◽  
Ott CV ◽  
Miskowiak KW
Keyword(s):  
Bipolar Disorder ◽  
Executive Function ◽  
Cognitive Remediation ◽  
Pre Treatment ◽  
Structural Brain

scholarly journals Executive Function Associated to Symptoms of Attention Deficit Hyperactivity Disorder and Paediatric Bipolar Disorder

2015 ◽  
Vol 28 (3) ◽  
pp. 544-553 ◽  
Author(s):  
Eva Angelina Araujo Jiménez ◽  
María Claustre Jané Ballabriga ◽  
Albert Bonillo Martin ◽  
Francisco Javier Arrufat
Keyword(s):  
Bipolar Disorder ◽  
Attention Deficit Hyperactivity Disorder ◽  
Executive Function ◽  
Attention Deficit ◽  
Hyperactivity Disorder ◽  
Paediatric Bipolar Disorder

P.0278 Structural brain abnormalities associated with cognitive impairments in bipolar disorder

2021 ◽  
Vol 53 ◽  
pp. S201
Author(s):  
J. Macoveanu ◽  
K.O. Freeman ◽  
H.L. Kjærstad ◽  
G.M. Knudsen ◽  
L.V. Kessing ◽  
...  
Keyword(s):  
Bipolar Disorder ◽  
Cognitive Impairments ◽  
Brain Abnormalities ◽  
Structural Brain

Executive Function in Patients with Remitted Bipolar Disorder and Schizophrenia and Its Relationship with Functional Outcome

2001 ◽  
Vol 71 (1) ◽  
pp. 39-46 ◽  
Author(s):  
A. Martínez-Arán ◽  
R. Penadés ◽  
E. Vieta ◽  
F. Colom ◽  
M. Reinares ◽  
...  
Keyword(s):  
Bipolar Disorder ◽  
Executive Function ◽  
Functional Outcome

scholarly journals Correction to: Effect of action-based cognitive remediation on cognition and neural activity in bipolar disorder: study protocol for a randomized controlled trial

Trials ◽  
2019 ◽  
Vol 20 (1) ◽  
Author(s):  
Caroline V. Ott ◽  
Maj Vinberg ◽  
Christopher R. Bowie ◽  
Ellen Margrethe Christensen ◽  
Gitte M. Knudsen ◽  
...  
Keyword(s):  
Bipolar Disorder ◽  
Randomized Controlled Trial ◽  
Study Protocol ◽  
Neural Activity ◽  
Controlled Trial ◽  
Cognitive Remediation ◽  
Randomized Controlled

scholarly journals Disturbances of Dynamic Function in Patients With Bipolar Disorder I and Its Relationship With Executive-Function Deficit

2020 ◽  
Vol 11 ◽  
Author(s):  
Yan Liang ◽  
Xiaoying Jiang ◽  
Wenjing Zhu ◽  
Yonghui Shen ◽  
Fengfeng Xue ◽  
...  
Keyword(s):  
Bipolar Disorder ◽  
Executive Function ◽  
Dynamic Function

An exploration of goal-setting for Cognitive Remediation Therapy in patients with bipolar disorder

2019 ◽  
Vol 254 ◽  
pp. 145-146
Author(s):  
D. Tsapekos ◽  
T. Mantingh ◽  
R. Strawbridge ◽  
A.H. Young
Keyword(s):  
Bipolar Disorder ◽  
Goal Setting ◽  
Cognitive Remediation ◽  
Cognitive Remediation Therapy

Correlation between white blood cell count and mood-stabilising treatment response in two bipolar disorder trials

2019 ◽  
Vol 31 (04) ◽  
pp. 230-234
Author(s):  
Ole Köhler-Forsberg ◽  
Louisa G. Sylvia ◽  
Charles L. Bowden ◽  
Joseph R. Calabrese ◽  
Michael E. Thase ◽  
...  
Keyword(s):  
Bipolar Disorder ◽  
Immune System ◽  
Blood Cell ◽  
Treatment Response ◽  
White Blood Cell ◽  
Standard Dose ◽  
Specific Treatment ◽  
Disorder Treatment ◽  
Pre Treatment ◽  
Personalised Treatment

AbstractBackground:Immune system markers may predict affective disorder treatment response, but whether an overall immune system marker predicts bipolar disorder treatment effect is unclear.Methods:Bipolar CHOICE (N = 482) and LiTMUS (N = 283) were similar comparative effectiveness trials treating patients with bipolar disorder for 24 weeks with four different treatment arms (standard-dose lithium, quetiapine, moderate-dose lithium plus optimised personalised treatment (OPT) and OPT without lithium). We performed secondary mixed effects linear regression analyses adjusted for age, gender, smoking and body mass index to investigate relationships between pre-treatment white blood cell (WBC) levels and clinical global impression scale (CGI) response.Results:Compared to participants with WBC counts of 4.5–10 × 109/l, participants with WBC < 4.5 or WBC ≥ 10 showed similar improvement within each specific treatment arm and in gender-stratified analyses.Conclusions:An overall immune system marker did not predict differential treatment response to four different treatment approaches for bipolar disorder all lasting 24 weeks.

Sign in / Sign up

Export Citation Format

Share Document